Effects of Physical Training on Adipose Tissue Metabolism and Insulin Sensitivity in the Menopausal Transition Phase

May 31, 2016 updated by: Bente Merete Stallknecht, University of Copenhagen

A Training Intervention Study in Late Pre- and Early Postmenopausal Women Investigating the Changes in Adipose Tissue Metabolism and Peripheral Insulin Sensitivity

The purpose of this study is to determine if physical exercise reduces the adverse changes in adipose tissue metabolism and insulin sensitivity that occurs in women during the menopausal transition.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

43

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen N, Denmark, 2200
        • Department og Biomedical Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 57 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Premenopausal OR Postmenopausal (45-57 years)
  • No chronical Diseases
  • BMI > 18,5 and < 30
  • Sedentary (no regular physical activity the last 2 years)
  • Either regular bleeding (premenopausal) OR no menstruation for at least 2 years (postmenopausal)
  • Plasma measurements:

Premenopausal: estradiol > 0.20nmol/l, Follicle Stimulating Hormone < 22 IU/l and progesterone > 2.5 nmol/l Postmenopausal: estradiol < 0.20nmol/l, Follicle Stimulating Hormone > 22 IU/l and progesterone from 0.3-2.5 nmol/l

Exclusion Criteria:

  • Smoking
  • Excessive alcohol intake
  • Regular medication including hormone replacement treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Premenopausal women
The premenopausal women will be attending Spinning classes.
After the baseline studies, the women will perform Spinning three times a week. Two of the sessions are performed on our location by trained instructors and the third training is self-training in a local fitness center where we provide free membership. All trainings are heart rate monitored.
Experimental: Postmenopausal Women
The postmenopausal women will be attending Spinning classes.
After the baseline studies, the women will perform Spinning three times a week. Two of the sessions are performed on our location by trained instructors and the third training is self-training in a local fitness center where we provide free membership. All trainings are heart rate monitored.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insulin stimulated uptake of glucose in adipose tissue
Time Frame: Baseline and 3 months
Measured by Positron Emission Tomography-Computed tomography (PET/CT)
Baseline and 3 months
Hyperinsulinemic euglycemic clamp
Time Frame: Baseline and 3 months
Glucose metabolized (mg/kg/min)
Baseline and 3 months
Adipose tissue distribution
Time Frame: Baseline and 3 months
Accessed by Magnetic Resonance Imaging (MRI).
Baseline and 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Central insulin sensitivity
Time Frame: Baseline and 3 months
Fasting plasma insulin, homeostasis model assessment insulin resistance and measures of central insulin sensitivity derived from an oral glucose tolerance test
Baseline and 3 months
Maximal oxygen uptake (ml/O2/kg/min)
Time Frame: Baseline and 3 months
Measured using indirect calorimetry and an incremental bicycle protocol
Baseline and 3 months
Metabolic syndrome
Time Frame: Baseline and 3 months
As measured by high density lipoprotein, triglycerides, waist circumference, blood pressure, mean arterial pressure, fasting glucose and composite metabolic syndrome scores
Baseline and 3 months
Health related quality of life
Time Frame: Baseline and 3 months
Measured using questionaries, semi-structured interviews and observations
Baseline and 3 months
Anthropometry
Time Frame: Baseline and 3 months
Measured using dual x-ray absorptiometry, height, weight, waist and hip circumference, sagittal abdominal height
Baseline and 3 months
Skeletal muscle biopsy
Time Frame: Baseline and 3 months
Biochemical, proteomics, metabolomics, genomics and morphological analyses
Baseline and 3 months
Abdominal subcutaneous adipose tissue biopsy
Time Frame: Baseline and 3 months
Biochemical, proteomics, metabolomics, genomics and morphological analyses
Baseline and 3 months
Resting metabolic rate
Time Frame: Baseline and 3 months
Will be measured by indirect calorimetry
Baseline and 3 months
Physical activity level and duration of sleep
Time Frame: Baseline and 3 months
Daily activity and duration of sleep will be recorded during one week using Actibelt® and self reporting
Baseline and 3 months
Microdialysis
Time Frame: Baseline and 3 months
Adipose tissue microdialysis
Baseline and 3 months
Femoral subcutaneous adipose tissue biopsy
Time Frame: Baseline and 3 months
Biochemical, proteomics, metabolomics, genomics and morphological analyses
Baseline and 3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dietary registration
Time Frame: Baseline and 3 months
Daily food intake for three week days and one week-end day will be reported by the subjects
Baseline and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ylva Hellsten, Proff., University of Copenhagen
  • Principal Investigator: Bente M Stallknecht, Proff. MD, University of Copenhagen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

January 1, 2016

Study Registration Dates

First Submitted

February 24, 2014

First Submitted That Met QC Criteria

March 3, 2014

First Posted (Estimate)

March 4, 2014

Study Record Updates

Last Update Posted (Estimate)

June 1, 2016

Last Update Submitted That Met QC Criteria

May 31, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • CWS menopause, adipose tissue

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insulin Resistance

Clinical Trials on Spinning

Subscribe